GORE TAG Conformable Thoracic Endoprosthesis TGU282815Recalls & reported problems
W. L. Gore & Associates, Inc. · TAG THORACIC ENDO CONFORM 28mmX15cm 20Fr · Class 3 · Implant
All models of GORE TAG Conformable Thoracic Endoprosthesis (20)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132618057), received between Jan 19, 2022 and Jan 19, 2022 — classified as 1 injury.
6 other recalls cover devices cleared under the same FDA submission (P040043); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 19, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2021 THE PATIENT UNDERWENT PART ONE OF A STAGED PROCEDURE TO TREAT A THORACOABDOMINAL AORTIC ANEURYSM USING A CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS (CTAG) IN THE GORE® EXCLUDER® (B)(6) CLINICAL TRIAL. ON (B)(6) 2022 A RETROPERITONEAL HEMATOMA WAS OBSERVED. IT WAS REPORTED THAT THE HEMATOMA WAS STUDY PROCEDURE RELATED. ON (B)(6) 2022 HEMATOMA EVACUATION WAS PERFORMED. THERE WERE NO FURTHER REPORTED ISSUES. THE PATIENT TOLERATED THE PROCEDURE AND IT WAS REPORTED THAT COMPUTED TOMOGRAPHY IMAGING WILL BE PERFORMED TO EVALUATE THE PLACEMENT OF THE CTAG DEVICE PRIOR TO COMPLETING THE (B)(6) PHASE OF THE STAGED PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13300431 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040043. One submission often covers many models, so check the product and lot details in each record.
- Z-0291-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
- Z-0290-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG CONFORMABLE Thoracic Stent Graft with ACTIVE CONTROL System
- Z-2052-2020 · Dec 17, 2019 · TerminatedConformable Thoracic Stent Graft, Rx only, Sterile EO - Product Usage: This device is intended for endovascular repair of lesions of the descending thoracic aorta.
- Z-0048-2018 · Sep 25, 2017 · TerminatedGORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta.
- Z-1237-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3415, 34mm x 15cm
- Z-1236-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3410, 34mm x 10cm
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page